When patients on these therapies develop yeast infections, it is more likely attributable to underlying diabetes, other medications (particularly SGLT2 inhibitors if used concomitantly), antibiotic use, or individual risk factors rather than the incretin-based agent itself
Your licensed provider will help set realistic expectations based on your personal health profile
This tells the pancreas to release more insulin when blood sugar rises, tells the liver to hold back a hormone that raises blood sugar, slows down digestion, and turns down appetite signals in the brain
Additionally, probiotics enhance the glucose-lowering/hypoglycemic effects of metformin by facilitating butyrate production, reflected by reductions in fasting blood glucose, insulin resistance, and fibronectin levels [148]